Health ❯ Healthcare

Treatment Methods

Innovative Therapies Immunotherapy Chemotherapy Therapies Radiation Therapy Targeted Therapy Physical Therapy Radiotherapy Pharmacology Transplantation

3 ARTICLES

last wk.

Registry-Based Digital Outreach Doubles Use of SGLT2 Drugs in Heart Failure Trial

Investigators say the approach could close treatment gaps by using health registries to find untreated patients then offering specialist phone visits.

3 ARTICLES

last mo.

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

4 ARTICLES

last mo.

Fecal‑Microbe Capsules Improve Sleep in Trial of Chronic Insomnia

3 ARTICLES

last mo.

Girl Given Years of Chemotherapy After Misdiagnosis as Family Files Formal Complaint

3 ARTICLES

2mo ago

Adani Foundation and Anushkaa Announce Three-Year Plan to Treat 10,000+ Children With Clubfoot

3 ARTICLES

3mo ago

Sanofi’s Efdoralprin Alfa Beats Standard Therapy in Phase 2 AATD Trial

3 ARTICLES

3mo ago

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

9 ARTICLES

3mo ago

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

11 ARTICLES

4mo ago

England Marks Major Shift Away From Blue Asthma Inhalers

3 ARTICLES

4mo ago

Preclinical Study Finds Low-Dose Cancer Drugs Restore Gut Barrier in Crohn’s Models

5 ARTICLES

4mo ago

Pilot Blood-Filtering Device Shows Early Promise for Severe Preeclampsia

4 ARTICLES

4mo ago

Toronto Patient’s HIV Is Undetectable After CCR5 Stem-Cell Transplant

3 ARTICLES

4mo ago

Stanford’s Low-Radiation Transplant Combo Reverses Type 1 Diabetes in Mice

3 ARTICLES

4mo ago

AI Uses DNA Methylation to Identify Primary Sites in Cancers of Unknown Primary

9 ARTICLES

4mo ago

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

3 ARTICLES

4mo ago

Greenebaum Family Foundation Gives $5.5 Million to University of Maryland Cancer Center

4 ARTICLES

4mo ago

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

Treatment Methods

Registry-Based Digital Outreach Doubles Use of SGLT2 Drugs in Heart Failure Trial

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

Fecal‑Microbe Capsules Improve Sleep in Trial of Chronic Insomnia

Girl Given Years of Chemotherapy After Misdiagnosis as Family Files Formal Complaint

McMaster Team Uses Phages to Disarm Crohn’s‑Linked E. coli

Study Maps How Leukemia Enters Lungs and Identifies Drug Targets

South Africa Begins National Rollout of Twice‑Yearly HIV Injection

Adani Foundation and Anushkaa Announce Three-Year Plan to Treat 10,000+ Children With Clubfoot

Sanofi’s Efdoralprin Alfa Beats Standard Therapy in Phase 2 AATD Trial

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

Never miss stories about

Treatment Methods

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

England Marks Major Shift Away From Blue Asthma Inhalers

Preclinical Study Finds Low-Dose Cancer Drugs Restore Gut Barrier in Crohn’s Models

Pilot Blood-Filtering Device Shows Early Promise for Severe Preeclampsia

Toronto Patient’s HIV Is Undetectable After CCR5 Stem-Cell Transplant

Stanford’s Low-Radiation Transplant Combo Reverses Type 1 Diabetes in Mice

AI Uses DNA Methylation to Identify Primary Sites in Cancers of Unknown Primary

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Greenebaum Family Foundation Gives $5.5 Million to University of Maryland Cancer Center

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

Never miss stories about

Treatment Methods